C1ORF83 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.267800E-01
Normal-vs-Stage2
4.132000E-01
Normal-vs-Stage3
2.469000E-01
Normal-vs-Stage4
4.238800E-01
Stage1-vs-Stage2
7.150200E-01
Stage1-vs-Stage3
1.864030E-01
Stage1-vs-Stage4
8.463000E-01
Stage2-vs-Stage3
9.886100E-02
Stage2-vs-Stage4
5.462400E-01
Stage3-vs-Stage4
5.968300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.964600E-01
Normal-vs-AfricanAmerican
2.557200E-01
Normal-vs-Asian
3.549800E-01
Caucasian-vs-AfricanAmerican
8.553600E-01
Caucasian-vs-Asian
5.351200E-01
AfricanAmerican-vs-Asian
5.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.604400E-01
Normal-vs-Female
4.441000E-01
Male-vs-Female
3.392300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.433400E-01
Normal-vs-Age(41-60Yrs)
4.630200E-01
Normal-vs-Age(61-80Yrs)
3.600400E-01
Normal-vs-Age(81-100Yrs)
2.459000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.754000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.656400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.937200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.517850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.156000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.868500E-02
Normal-vs-Daily Drinker
3.288200E-01
Normal-vs-Weekly Drinker
3.172400E-01
Normal-vs-Occasional Drinker
4.018800E-01
Normal-vs-Social Drinker
4.634000E-01
Non Drinker-vs-Daily Drinker
3.307600E-01
Non Drinker-vs-Weekly Drinker
3.086800E-01
Non Drinker-vs-Occasional Drinker
9.801800E-01
Non Drinker-vs-Social Drinker
5.457800E-01
Daily Drinker-vs-Weekly Drinker
8.553200E-01
Daily Drinker-vs-Occasional Drinker
2.533000E-01
Daily Drinker-vs-Social Drinker
1.002960E-01
Weekly Drinker-vs-Occasional Drinker
1.613250E-01
Weekly Drinker-vs-Social Drinker
6.640100E-02
Occasional Drinker-vs-Social Drinker
4.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.489000E-01
Normal-vs-Grade 2
8.025000E-01
Normal-vs-Grade 3
7.880400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.044000E-02
Grade 1-vs-Grade 3
8.356000E-02
Grade 1-vs-Grade 4
8.489000E-01
Grade 2-vs-Grade 3
7.865200E-01
Grade 2-vs-Grade 4
8.025000E-01
Grade 3-vs-Grade 4
7.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.687400E-01
Normal-vs-NonDiabetic
3.651800E-01
Diabetic-vs-NonDiabetic
9.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.174400E-01
Normal-vs-NoPancreatitis
3.690800E-01
Pancreatitis-vs-NoPancreatitis
5.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.690400E-01
Normal-vs-N1
4.137800E-01
N0-vs-N1
2.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.760600E-01
Normal-vs-TP53-NonMutant
4.818000E-01
TP53-Mutant-vs-TP53-NonMutant
9.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
